Pharmaceutical Engineering of Lipid-Based Nanocarriers for Cancer Nanomedicines: From Doxorubicin to mRNA Platforms.
- DOI
- 10.1021/acsbiomaterials.6c00618
- Published
- 2026 Aug 10
- Container
- ACS biomaterials science & engineering
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acsbiomaterials.6c00618,
title = {Pharmaceutical Engineering of Lipid-Based Nanocarriers for Cancer Nanomedicines: From Doxorubicin to mRNA Platforms.},
author = {Gillman L and Suleski D and Graham ME and Ginn SL and Hassan MM},
year = {2026},
journal = {ACS biomaterials science \& engineering},
doi = {10.1021/acsbiomaterials.6c00618},
url = {https://doi.org/10.1021/acsbiomaterials.6c00618}
}RIS
TY - JOUR TI - Pharmaceutical Engineering of Lipid-Based Nanocarriers for Cancer Nanomedicines: From Doxorubicin to mRNA Platforms. AU - Gillman L AU - Suleski D AU - Graham ME AU - Ginn SL AU - Hassan MM PY - 2026 JO - ACS biomaterials science & engineering DO - 10.1021/acsbiomaterials.6c00618 UR - https://doi.org/10.1021/acsbiomaterials.6c00618 ER -
APA
L, G., D, S., ME, G., SL, G., & MM, H. (2026). Pharmaceutical Engineering of Lipid-Based Nanocarriers for Cancer Nanomedicines: From Doxorubicin to mRNA Platforms.. ACS biomaterials science & engineering. https://doi.org/10.1021/acsbiomaterials.6c00618
Source records
- pubmed · retrieved 2026-09-26T12:10:43.082Z
- europe-pmc · retrieved 2026-09-26T12:10:43.082Z